Buy CJC-1295/Ipamorelin Blend 5 MG | Atomix Research
$59.99
Order CJC-1295 and Ipamorelin blend from Atomix Research. Dual peptide formula with verified COA, high purity, and reliable quality for research use only.
Description
The CJC-1295/Ipamorelin Blend combines two well-studied peptides that act synergistically on growth hormone pathways. CJC-1295 (a modified GHRH analogue) stimulates pulsatile release of growth hormone, while Ipamorelin (a selective ghrelin receptor agonist) enhances this effect without significantly impacting cortisol, prolactin, or ACTH levels. Together, they provide a potent and selective model for investigating growth hormone dynamics, tissue repair, metabolism, and age-related endocrine decline in preclinical research.
Supplied as a lyophilized powder blend in vials (5 mg CJC-1295 and 5 mg Ipamorelin). Store at –20 °C for long-term preservation, protected from light and moisture. After reconstitution with sterile water or buffer, aliquot and store at 2–8 °C for short-term use or –20 °C for extended stability. Avoid repeated freeze–thaw cycles.
For laboratory research use only. Not for human or veterinary use. Not a drug, food, or cosmetic.
| Synonyms | CJC-1295 + Ipamorelin, Modified GRF (1-29) + Ipamorelin |
| Composition | CJC-1295 (5 mg) + Ipamorelin (5 mg) |
| Molecular Formulas | CJC-1295: C152H252N44O42 Ipamorelin: C38H49N9O5 |
| Molecular Weight | CJC-1295: ~3367.9 g/mol Ipamorelin: ~711.9 g/mol |
| CAS Numbers | CJC-1295: 863288-34-0 Ipamorelin: 170851-70-4 |
| Appearance | White lyophilized powder |
